Your search for lung cancer returned 922 results

The decision to withdraw Exkivity was made after the confirmatory trial failed to meet the primary endpoint.

Higher major pathological response seen for patients with resectable NSCLC treated with combo versus durvalumab alone.

A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.

New research suggests that mRNA COVID-19 vaccines can elevate PD-L1 expression levels in patients with advanced non-small cell lung cancer.

Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.

Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse.

Responses are moderately understandable, not readily actionable, and written at college reading level.

AI chatbots can sometimes provide accurate information about cancers, but these tools have significant limitations.

Starting treatment for advanced NSCLC before receiving genomic test results compromises patient outcomes, a study suggests.

Phase 3 trial results suggest that it’s time to move away from using dexamethasone as an antiemetic, said Venkatraman Radhakrishnan, MD.